Gilead Sciences Inc. (GILD)
-NasdaqGS | Prev Close: | 56.47 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 63.88 |
|---|
| Beta: | 0.81 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 24.12 - 57.10 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 11,794,900 |
|---|
| Market Cap: | 86.14b |
|---|
| P/E (ttm): | 31.62 |
|---|
| EPS (ttm): | 1.79 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Key Statistics
| Forward P/E (1 yr): | 19.47 |
|---|
| P/S (ttm): | 8.66 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.98 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.49 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | 1.13 |
|---|
Business Summary
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia.
more 